Hi @Peeteepoo,
Given they manage to start recruiting at Healey platform end of this year,
would it be reasonable to assume, that we start getting readouts mid-next year?
obviously the trial would be ongoing, but we get a glimpse of what's happening during the trial?
And also because the drug is repurposed, so risks are less compared to a brand new drug, for instance? Nothing guaranteed but is that a fair assumption?
I reckon once the Healey starts recruiting, fomo would start building imo.
ps-I like the risk-reward here, and topped up today also
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$, page-284
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
-0.003(1.45%) |
Mkt cap ! $82.69M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.5¢ | 16.8¢ | $85.23K | 500.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 246513 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 40455 | 4 |
View Market Depth
| Last trade - 16.10pm 16/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |